Atea Pharmaceuticals, Inc. announced it raised $107 Million in an initial filing from an offering of $215 Million

May 29, 2020•over 5 years ago

Amount Raised

$107 Million

BostonBiotechnology

Company Information

Company

Atea Pharmaceuticals, Inc.

Location

125 SUMMER ST.

Boston, Massachusetts, United States

About

Atea Pharmaceuticals is a leader in the discovery of oral direct-acting antiviral therapies, including our most advanced drug candidate, AT-527.

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech